Publications by authors named "Anya Polovina"

Claim this Profile
I
INBRX-106: a hexavalent OX40 agonist that drives superior antitumor responses via optimized receptor clustering.
Nisha Holay, Rashi Yadav, Sae Jeong Ahn, Melissa J Kasiewicz, Anya Polovina

J Immunother Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
INBRX-120, a CD8α-targeted detuned IL-2 that selectively expands and activates tumoricidal effector cells for safe and durable in vivo responses.
Florian J Sulzmaier, Nadja Kern, Sae Jeong Ahn, Anya Polovina, Jason Ho

J Immunother Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis